Replimune Group, Inc. - Common Stock (NQ:REPL)
All News about Replimune Group, Inc. - Common Stock
Replimune Announces Type A Meeting Scheduled with FDA
September 02, 2025
From Replimune, Inc.
Via GlobeNewswire
Via NewMediaWire
Topics
Lawsuit
Via NewMediaWire
Topics
Lawsuit